Nuedexta in Agitated Dementia

Topics: Agitation | Dementia | Generics | Nuedexta | Pharmaceutical Industry | pseudobulbar affect

Treating agitation in dementia is no easy task. Behavioral interventions are first line, but they are difficult to implement and often insufficient. Psychotropics show modest benefits, but they are prone to causing adverse events. Benzodiazepines can precipitate falls, disinhibition, and confusion. Antipsychotics have a black box warning about an increa